Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data (Q30620889)

16 August 2017

1 reference

24 August 2020

1 reference

PubMed publication ID

23639488

comparative study

1 reference

PubMed publication ID

23639488

title

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data (English)

1 reference

selective estrogen-receptor modulators

16 August 2017

1 reference

24 August 2020

1 reference

11 August 2020

1 reference

24 August 2020

1 reference

1 reference

1 reference

1 reference

Ivana Sestak

1 reference

16 August 2017

Mitch Dowsett

1 reference

16 August 2017

Andrea Z LaCroix

1 reference

16 August 2017

Umberto Veronesi

1 reference

16 August 2017

Jack Cuzick

1 reference

16 August 2017

Bernardo Bonanni

1 reference

16 August 2017

Joseph P Costantino

1 reference

16 August 2017

Steve Cummings

1 reference

16 August 2017

Andrea DeCensi

1 reference

16 August 2017

John F Forbes

1 reference

16 August 2017

Leslie Ford

1 reference

16 August 2017

John Mershon

1 reference

16 August 2017

Bruce H Mitlak

1 reference

16 August 2017

Trevor Powles

1 reference

16 August 2017

Victor Vogel

1 reference

16 August 2017

D Lawrence Wickerham

1 reference

16 August 2017

SERM Chemoprevention of Breast Cancer Overview Group

1 reference

16 August 2017

language of work or name

English

0 references

publication date

30 April 2013

1 reference

16 August 2017

25 May 2013

6 references

13 March 2019

3 April 2019

17 June 2019

17 November 2019

11 August 2020

24 August 2020

7 references

16 August 2017

13 March 2019

3 April 2019

17 June 2019

17 November 2019

11 August 2020

24 August 2020

381

1 reference

16 August 2017

9880

1 reference

16 August 2017

1827-1834

1 reference

Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women.

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Lasofoxifene in postmenopausal women with osteoporosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Aromatase inhibitors in prevention--data from the ATAC (arimidex, tamoxifen alone or in combination) trial and the design of IBIS-II (the second International Breast Cancer Intervention Study).

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Overview of the main outcomes in breast-cancer prevention trials

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Exemestane for breast-cancer prevention in postmenopausal women

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3671272

Tamoxifen and contralateral breast cancer

25 November 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960140-3

7 January 2021

Chemoprevention of breast cancer with selective oestrogen-receptor modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960140-3

7 January 2021

Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960140-3

7 January 2021

The Combination of Estimates from Different Experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960140-3

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960140-3

7 January 2021

Mammographic Density and the Risk and Detection of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960140-3

7 January 2021

10.1016/S0140-6736(13)60140-3

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

23639488

1 reference